Literature DB >> 3013685

Several lines of evidence demonstrating that Plasmodium falciparum, a parasitic organism, has distinct enzymes for the phosphorylation of choline and ethanolamine.

M L Ancelin, H J Vial.   

Abstract

In Plasmodium falciparum-infected erythrocyte homogenates, the specific activity of ethanolamine kinase (7.6 +/- 1.4 nmol phosphoethanolamine/10(7) infected cells per h) was higher than choline kinase specific activity (1.9 +/- 0.2 nmol phosphocholine/10(7) infected cells per h). The Km of choline kinase for choline was 79 +/- 20 microM, and ethanolamine was a weak competitive inhibitor of the reaction (Ki = 92 mM). Ethanolamine kinase had a Km for ethanolamine of 188 +/- 19 microM, and choline was a competitive inhibitor of ethanolamine kinase with a very high Ki of 268 mM. Hemicholinium 3 inhibited choline kinase activity, but had no effect on ethanolamine kinase activity. In contrast, D-2-amino-1-butanol selectively inhibited ethanolamine kinase activity. Furthermore, when the two enzymes were subjected to heat inactivation, 85% of the choline kinase activity was destroyed after 5 min at 50 degrees C, whereas ethanolamine kinase activity was not altered. Our results indicate that the phosphorylation of choline and ethanolamine was catalyzed by two distinct enzymes. The presence of a de novo phosphatidylethanolamine Kennedy pathway in P. falciparum contributes to the bewildering variety of phospholipid biosynthetic pathways in this parasitic organism.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3013685     DOI: 10.1016/0014-5793(86)80690-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  Phospholipid metabolism of serine in Plasmodium-infected erythrocytes involves phosphatidylserine and direct serine decarboxylation.

Authors:  N Elabbadi; M L Ancelin; H J Vial
Journal:  Biochem J       Date:  1997-06-01       Impact factor: 3.857

2.  4-amino bis-pyridinium derivatives as novel antileishmanial agents.

Authors:  Verónica Gómez-Pérez; José Ignacio Manzano; Raquel García-Hernández; Santiago Castanys; Joaquín M Campos Rosa; Francisco Gamarro
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

3.  Inhibition of Plasmodium falciparum choline kinase by hexadecyltrimethylammonium bromide: a possible antimalarial mechanism.

Authors:  Vinay Choubey; Pallab Maity; Mithu Guha; Sanjay Kumar; Kumkum Srivastava; Sunil Kumar Puri; Uday Bandyopadhyay
Journal:  Antimicrob Agents Chemother       Date:  2006-12-04       Impact factor: 5.191

Review 4.  Parasite-regulated membrane transport processes and metabolic control in malaria-infected erythrocytes.

Authors:  B C Elford; G M Cowan; D J Ferguson
Journal:  Biochem J       Date:  1995-06-01       Impact factor: 3.857

Review 5.  Lipid synthesis in protozoan parasites: a comparison between kinetoplastids and apicomplexans.

Authors:  Srinivasan Ramakrishnan; Mauro Serricchio; Boris Striepen; Peter Bütikofer
Journal:  Prog Lipid Res       Date:  2013-07-01       Impact factor: 16.195

6.  Labeling and initial characterization of polar lipids in cultures of Plasmodium falciparum.

Authors:  A Dieckmann-Schuppert; S Bender; A A Holder; K Haldar; R T Schwarz
Journal:  Parasitol Res       Date:  1992       Impact factor: 2.289

7.  Increased permeability to choline in simian erythrocytes after Plasmodium knowlesi infection.

Authors:  M L Ancelin; M Parant; M J Thuet; J R Philippot; H J Vial
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

8.  Contribution of the precursors and interplay of the pathways in the phospholipid metabolism of the malaria parasite.

Authors:  Sharon Wein; Salma Ghezal; Corinne Buré; Marjorie Maynadier; Christian Périgaud; Henri J Vial; Isabelle Lefebvre-Tournier; Kai Wengelnik; Rachel Cerdan
Journal:  J Lipid Res       Date:  2018-05-31       Impact factor: 5.922

9.  Plasmodium falciparum Choline Kinase Inhibition Leads to a Major Decrease in Phosphatidylethanolamine Causing Parasite Death.

Authors:  Lucía Serrán-Aguilera; Helen Denton; Belén Rubio-Ruiz; Borja López-Gutiérrez; Antonio Entrena; Luis Izquierdo; Terry K Smith; Ana Conejo-García; Ramon Hurtado-Guerrero
Journal:  Sci Rep       Date:  2016-09-12       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.